Objective
To analyse the impact of centralisation of radical cystectomy (RC) provision for bladder cancer in England, on postoperative mortality, length of stay (LoS), complications and reintervention rates, from implementation of centralisation from 2003 until 2014. In 2002, UK policymakers introduced the 'Improving Outcomes Guidance' (IOG) for urological cancers after a global cancer surgery commission identified substantial shortcomings in provision of care of RCs. One key recommendation was centralisation of RCs to high-output centres. No study has yet robustly analysed the changes since the introduction of the IOG, to assess a national healthcare system that has mature data on such institutional transformation.
Patients and Methods
RCs performed for bladder cancer in England between 2003/ 2004 and 2013/2014 were analysed from Hospital Episode Statistics (HES) data. Outcomes including 30-day, 90-day, and 1-year all-cause postoperative mortality; median LoS; complication and re-intervention rates, were calculated. Multivariable statistical analysis was undertaken to describe the relationship between each surgeon and the providers' annual case volume and mortality.
Results
In all, 15 292 RCs were identified. The percentage of RCs performed in discordance with the IOG guidelines reduced from 65% to 12.4%, corresponding with an improvement in 30-day mortality from 2.7% to 1.5% (P = 0.024). Procedures adhering to the IOG guidelines had better 30-day mortality (2.1% vs 2.9%; P = 0.003) than those that did not, and better 1-year mortality (21.5% vs 25.6%; P < 0.001), LoS (14 vs 16 days; P < 0.001), and re-intervention rates (30.0% vs 33.6%; P < 0.001). Each single extra surgery per centre reduced the odds of death at 30 days by 1.5% (odds ratio [OR] 0.985, 95% confidence interval [CI] 0.977-0.992) and 1% at 1 year (OR 0.990, 95% CI 0.988-0.993), and significantly reduced rates of re-intervention.
Introduction
In 2015, a global commission on cancer surgery identified substantial shortcomings in provision of care, and was able to provide several key areas for improvement [1] . Amongst these was the importance of surgical volume, processes, and outcomes, for delivering safe and effective cancer surgery. Super-centralisation of surgical services was proposed as one possible solution.
There is an ongoing reconfiguration of cancer surgery services in the UK in response to the NHS Cancer Plan and 'Improving Outcomes Guidance' (IOG) released over a decade ago [2] . One of the key recommendations of these guidelines was the centralisation of radical cystectomies (RCs) for bladder cancer to high-output centres. The IOG guidelines recommended that radical surgery for prostate and bladder cancer should be provided by teams serving populations of 1 million or more, and carrying out a cumulative total of ≥50 operations per annum. Surgeons carrying out small numbers of either operation (a total of five or less per annum) were advised to refer this work on to more specialised colleagues. The overall aim was to reduce the 30-day mortality rate to ≤3.5% for all providers and surgeons performing RCs across the UK. Since these guidelines were published there has been a shift in the national distribution of RCs to high-output centres [3] .
The volume-outcome relationship for RCs has been previously described, indicating a consistent inverse association between increased surgical workload and outcomes, including mortality and postoperative complications [4, 5] . The main body of evidence supports the centralisation process for RCs [6] [7] [8] [9] [10] [11] .
However, due to the complexity of this debate, doubts remain about a direct link between centralisation and improved outcomes. Furthermore, the methodological cogency of some of the published literature has also come under scrutiny [11] [12] [13] .
The location and number of RCs performed in the NHS in England are all recorded in the Hospital Episode Statistics (HES) database, allowing the centralisation process to be tracked. The HES also records patient demographics and other variables including postoperative complications. We reviewed the postoperative outcomes for RCs performed in England over the 11-year period following the introduction of the IOG guidelines for urological cancers, to ascertain the nature and describe the impact of reconfiguration of RC provision.
Patients and Methods

Database Inclusions and Variable Coding
All adult patients aged ≥18 years, resident in England undergoing a RC with a diagnosis of bladder cancer, with admission dates between 1 April 2003 and 31 March 2014, were included in the analysis. RCs were identified using the Office of Population Censuses and Surveys Classification of Interventions and Procedures (OPCS-4) codes M34*, and prostatectomies were ascertained using code M61*. Bladder cancer was identified using the International Statistical Classification of Diseases and Related Health Problems 10th revision (ICD-10) code C67*. We excluded all procedures where the total length of stay (LoS) for the RC patient was ≤2 days and where there was no record of the patient dying in hospital.
The number of prostatectomies and RCs performed in each centre each year was also extracted. Procedures were identified as 'IOG compliant' if the centre where the surgery took place had conducted ≥50 prostatectomies and RCs; and if the operating surgeon had performed more than five of either type of surgery in that year.
Patient Demographic Variables
Patient's age; gender; ethnicity; index of multiple deprivation (IMD) 2007 score, and Charlson Comorbidity Index (CCI) score, were extracted for each procedure. The CCI score predicts 1-year mortality for a patient who may have a range of comorbidities, and is considered in three categories: 0, 1-4, and ≥5. The IMD is an overall score of deprivation derived from seven domains; 'income', 'employment', 'health', 'education', 'training and skills', 'barriers to housing and services', 'crime and living environment'. Scores were used in models as a continuous variable, but quintiles derived from these scores; classified from 1 (most deprived) to 5 (least deprived) were also used for categorical comparisons.
Outcome Variables
We ascertained 30-, 90-day, and 1-year all-cause postoperative mortality. Deaths within 1 year were ascertained through linkage between HES records and the Office of National Statistics mortality data based on death certificates. The LoS is the time (in days) spent in hospital during the primary admission for RC. The median LoS (with interquartile range [IQR] ) is referred to in unadjusted analyses. Complications and re-interventions were calculated using the coding set out in Mayer et al. [14] .
Data Exclusions
Records in the HES database are for 'hospital episodes' that relate to a period of care for a patient under a single specialist. A stay in hospital can consist of one or more episodes of care. For each RC, if no date of discharge was available on the episode, but was included in another episode within the same stay then that date of discharge was used. Records with no updateable discharge date were excluded, as it was not possible to calculate LoS. If there was a date of death that occurred >1 day before the procedure, then the record was removed as it is not possible to tell whether an error in data linkage had occurred. For those where the date of death occurred the day before the procedure and the HES record stated that the patient died during the stay, then the length of time between operation and death was updated to zero days. Patients with no recorded age or sex were also removed from analyses as these two variables are always used in determining patient identity along with NHS number. Patients whose region of residence was recorded as being outside of England or where this information was not available were also removed from analysis as follow-up may have occurred elsewhere.
Univariable and Multivariable Analysis
Categorical variables were tested for association with the 30-day and 1-year outcome variables using the chi-squared test. Kaplan-Meier survival curves were produced to examine survival over time. Results of multivariable mixed effects logistic regression was used to investigate 30-day death rates, complication rates, re-intervention rates, and deaths within 1 year of the operation, adjusting for factors that may have an impact on outcome (Table 1) . To account for uncaptured differences at each hospital, a centre-level random effect was added when considering the effects of the number of procedures per centre. Survival was modelled using Cox regression. For all regression models, continuous variables were fitted using suitable transformations, such as a log transformation of IMD and CCI scores, and a cubic spline for age. The multivariable models were first fitted with all variables; and then tested to see whether any variables could be excluded from the analyses.
Statistical analyses were carried out using the R statistical package (version 3.0; The R Foundation for Statistical Computing c/o Institute for Statistics and Mathematics, Vienna, Austria). A P < 0.05 was considered statistically significant in the analysis.
Results
Centralisation
The study included 15 292 RCs; 11 793 (71.1%) in male patients and 3 499 (22.9%) in females, with a median (IQR) age of 69 (62-74) years. Most of the patients did not have a comorbidity recorded (53.8%) and 16.0% came from the most deprived regions, according to IMD scores.
During the study period there was a clear trend toward centralisation of provision of RCs: the number of operations performed increased annually, and the number of urological surgeons and providers performing RCs reduced annually (Fig. 1) . The percentage of RCs performed by a provider in discordance with the IOG guidelines reduced each year, from 52.7% in 2003 to 2.0% in 2013 (Fig. 2) . The percentage of RCs performed by a surgeon in discordance with the IOG guidelines also reduced each year, from 29.9% in 2003 to 11.1% in 2013 (Fig. 2) . By 2013, the percentage of RCs being performed in discordance with the IOG guidelines on provider or surgeon volume was 12.4%, a reduction from 65% in 2003 (Fig. 2) . Over the 11-year period there was a significant improvement in the overall 30-day crude mortality rate with a reduction from 2.7% to 1.5% (P = 0.024), and 90-day crude mortality dropped from 7% to 4%. The number of providers Fig. 3 ). The IOG-compliant group showed significantly better 30-day mortality rates (2.1% vs 2.9%; P = 0.003), 90-day mortality rates (5.2% vs 7.2%; P < 0.001), 1-year mortality rates (21.5% vs 25.6%; P < 0.001), LoS (14 vs 16 days; P < 0.001), and re-intervention rates (30.0% vs 33.6%; P < 0.001) compared to the IOG-non-compliant group (Fig. 3) . The IOG-compliant group also had an increased median survival time over the IOG-non-compliant group: 5.41 years (95% CI 5.05-5.85) vs 4.07 (95% CI 3.69-4.50; Fig. 3) . When censoring the data at 90 days, the IOG-non-compliant group had a median survival of 5.1 years, whereas for those in the IOG-compliant group it was 6.4 years (P < 0.001). Adjusting for age, comorbidities, gender, and deprivation, discordance with IOG guidelines increased the hazard of death (hazard ratio [HR] 1.17, 95% CI 1.12-1.23). Furthermore, the incremental effect of increasing the number of procedures conducted by a provider by one significantly reduced the hazard of death (HR 0.993, 95% CI 0.992-0.995).
Discussion
To our knowledge, this is the largest UK study to date robustly assessing the process of centralisation of RC provision. A recent study by Hounsome et al. [15] investigated outcomes after RC since the introduction of IOG guidelines until 2010, but their analyses only provided circumstantial evidence, as the comparison of outcomes between IOG-compliant and IOG-non-compliant centres was not made. When analysing survival outcomes, they compared outcomes with nationally representative background rates, making no comment on the impact on the effects of centralisation, and importantly, adjustment for important potential confounders, such as the changing age of the population during this time, amongst others, was not made. Our present analyses directly compared the outcomes of patients undergoing operations from IOG-compliant and IOG-non-compliant centres, with multivariable adjustment for several known confounders.
Due to the complexity of the IOG guidelines, flexibility was originally given around implementation timescales, but it soon became apparent that local health economies had deferred action in favour of other priorities. This was addressed by employment of agreed milestones for health authorities after 2006, and our results show a clear and profound acceleration in centralisation of RCs provision after that date, which reaches a plateau after 2011 (Fig. 2) . This finding corroborates the Lancet Oncology Commission's suggestion of the importance of politics and policy in this area.
There has been a clear trend in centralisation since the publication of the IOG guidelines in 2002. The number of RCs has risen each year but the number of providers and surgeons have dropped (Fig. 1) . In 2003/2004 there were 290 surgeons and 135 providers, reducing to 199 surgeons and 60 providers by 2013/2014 (Fig. 1) . RCs performed in concordance with the IOG guidelines following its publication have an improved 30-day and 1-year mortality rates over those in discordance. Furthermore, the median overall survival rates were significantly improved for IOG-compliant procedures (5.41 years) over IOG-non-compliant procedures (4.07 years).
The difference seen in survival outcomes in our present study between IOG-compliant and IOG-non-compliant procedures is more marked than those described in previous studies in the UK [14, 16, 17] . This disparity may well be as a result of the acceleration in centralisation noted after 2007. The last national study in England looking at outcomes of RCs with specific analysis of the impact of centralisation, only analysed information up to 2007, just 5 years after the IOG guidelines had been introduced, when 56.1% of RCs were still in discordance with the IOG guidelines (Fig. 2) . By 2011/2012, only 12.5% of RCs were in discordance with the IOG guidelines (Fig. 2) .
The present study strengthens the link between high-volume providers and improved outcomes, by including all surgeons and centres therefore analysing 'real data', but has not addressed how this is occurring. An exact cause-effect relationship is unlikely to be formulated, but the relationship is most probably multifactorial [18, 19] . There are numerous potential reasons for the superior outcomes seen. Firstly, high patient volumes have inherent benefits ranging from increased surgeon experience to improved numbers for audits, trials, and research. A good example is robotic surgery, which requires high numbers of patients per year to be cost-effective [20] . High-volume providers also often have additional services at their disposal, which may improve perioperative selection of patients, allow for adoption of enhanced recovery pathways, provide additional treatments, improve treatment of postoperative complications, and improve follow-up and surveillance of patients [18] . Furthermore, local access to specialist oncology and radiotherapy services at high-volume centres may impact overall survival. Finally, having fewer hospitals performing a certain type of highly complicated intervention allows better regulation and provision of more uniform and consistent care.
There are an increasing number of RCs being performed each year, even though the number of newly diagnosed bladder cancers is decreasing [21] . As outcomes have improved more patients who are aged >70 years or have serious comorbidities are being considered suitable for surgery [22] . The majority of this group of patients are being operated on at high-volume centres by high-volume surgeons (Table 2 ). Our present finding that over the 11-year period crude 30-day mortality dropped from 2.7% to 1.5% is encouraging, but remains sub-optimal given previously described single-centre experiences of significantly better outcomes both in the UK and USA [23] [24] [25] . However, a clear correlation between the process of centralisation in the last decade and improved
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© 2017 The Authors BJU International © 2017 BJU International survival after RC is shown in the present study. Indeed, when the adjusted number of procedures per centre was modelled, with each single extra surgery the odds of death significantly reduced at 30 days and at 1 year, as did re-intervention rates. This is a novel observation that has not been published previously.
Several papers have been critical of using the HES database, due in part to coding errors [26] . Potential sampling bias exists and there is the possibility that a very small number of patients with RCs were not captured. Furthermore, there will undeniably be an impact on our present findings from hospital mergers and closures, although these would account for a very small proportion of our dataset. Nevertheless, a core limitation of the present study is that it is a secondary analysis of administrative data; therefore misclassification bias may exist due to coding errors. We were not able to fully capture the outcomes of outpatient visits and records of potentially minor events. Our minor complication rates were therefore lower than those reported by singleinstitution series [27, 28] . Detailed oncological information, such as chemotherapy, stage and grade of muscle-invasive bladder cancer, was also not fully captured in the present review. England, unlike North America or other European countries is geographically very tight within a single healthcare service (NHS England). We recognise this as an assumption and therefore a potential limitation to the study [29] . However, the Cancer registry (Office of National Statistics) suggests that region wide stage-specific variations are uniform across England. Hence, we can presume that the disease characteristics between the IOG-compliant and IOG-non-compliant centres are also uniform.
Moreover, the retrospective nature of the present analysis means that potential unmeasured confounders that can account for differences in outcomes, such as smoking status [29] , albumin levels [30, 31] , and outpatient management strategies, will not be captured. Surgeon skill and experience is another potential uncaptured confounder, as the BAUS annual workforce reports at the beginning and end of the study period show the composition of the surgical workforce changed greatly.
In our present methodology we have taken steps to minimise the impact of potential coding errors, and although coding errors are likely to have a bearing on our results we feel this will be negligible. The key search criteria of bladder cancer and RC along with outcomes, such as mortality and LoS, leave little space for interpretation. Furthermore, it is noteworthy that our present analysis is of a population-based dataset and no statistical assumptions or weighting was necessary to achieve patient numbers, unlike some previous studies [32] . Given the association between centralisation and improved outcomes in RCs over the last decade described in the present study, it would be logical to consider that continuation of the centralisation process could further enhance outcomes. This raises the question of the optimum number of centres and surgeons needed to achieve the most favourable outcomes and, whether a decade on from the IOG, new guidance needs to be provided to optimise service reconfiguration.
Since the first volume-outcome relationships in medical care were reported by Luft et al. [33] in 1979, there has been a persistent and sometimes emotional debate about whether certain sorts of complex, elective care should be restricted to high-volume medical centres. A decade ago the IOG set out to centralise surgical care for cancer as one method for improving cancer outcomes in the UK, yet a robust and up-to-date review of this process is lacking in the literature. Our group's analysis of RCs provides this information for just one cancer type, but goes some way to showing the impact of centralisation. We have shown that the variance in outcomes between high-and low-volume surgeons and providers is more profound than that shown by any previous UK studies. We have also shown a sudden and steep acceleration of the process of centralisation after 2007, indicative of the NHS Cancer Reform Strategy, which sought to push for concordance with the IOG; no studies have extensively analysed outcomes after this date. The effects of caseload levels for surgeons and providers proposed in the present study, including the fact that a single extra procedure per year per centre can significantly reduce mortality and reintervention rates, may serve to offer healthcare planners an evidence base to propose new guidance for further optimisation of RC provision.
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